Recombinant Adenovirus Vectors Activate the Alternative Complement Pathway, Leading to the Binding of Human Complement Protein C3 Independent of Anti-Ad Antibodies
Open Access
- 1 December 2004
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 10 (6) , 1140-1142
- https://doi.org/10.1016/j.ymthe.2004.08.015
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Complement activation by recombinant adenovirusesGene Therapy, 2001
- Capsule Production and Growth Phase Influence Binding of Complement toStaphylococcus aureusInfection and Immunity, 2001
- Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal proteinThe Journal of Gene Medicine, 2000
- Pre-Existent Adenovirus Antibody Inhibits Systemic Toxicity and Antitumor Activity of CN706 in the Nude Mouse LNCaP Xenograft Model: Implications and Proposals for Human TherapyHuman Gene Therapy, 2000
- Controlling the complement system in inflammationImmunopharmacology, 1997